BNET Industries
- Private
- CA
Dow Jones Description
Only 30 minutes from the heart of downtown Vancouver, the University of British Columbia holds an international reputation for excellence in advanced research and learning. The spectacular UBC campus is a 'must-see' for any visitor to the city -- where snow-capped mountains meet ocean, and breathtaking vistas greet you around every corner. The university boasts some of the city's best attractions & recreation facilities, including the Museum of Anthropology, the Chan Centre for the Performing Arts, the UBC Botanical Garden and Centre for Plant Research, and endless opportunities to explore forested trails in the adjoining 763-hectare Pacific Spirit Regional Park.
Contact Information
2329 West Mall
Vancouver, British Columbia V6T 1Z4
604.822.2211
NAICS Code Colleges, Universities, and Professional Schools: 611310
News & Analysis
Filter by
conference and healthcare and university of british columbia - All News and Analysis
MIV Therapeutics to Present at the BMO Capital Markets Focus on Healthcare Conference
- 2007-11-26
MIV Therapeutics, Inc. (OTCBB: MIVT) (FRANKFURT: MIV), a leading developer of next-generation coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, today announced that Dr. Mark Landy, president of MIV Therapeutics, will present a company overview at the BMO Capital Markets Focus On Healthcare Conference...
MIV Therapeutics to Present Advanced Biocompatible Stent-Coating Technology at International Biomaterials Conference; Senior Scientist Invited to Review Data at 19th International Symposium on Ceramics in Medicine in China
- 2006-08-15
ATLANTA -- MIV Therapeutics (OTCBB:MIVT)(FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, is scheduled present the highly encouraging development progress of the Company's Hydroxyapatite HAp coatings for coronary stents and other devices at the 19th International Symposium...
MIV Therapeutics Highlights HAp Composite Coating Technologies at Leading Conference on Biomaterials; Better, Safer, More Biocompatible Stent Coating Technologies Presented at Recent International Society of Biomaterials Meeting
- 2006-05-08
VANCOUVER, British Columbia -- MIV Therapeutics, Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of new generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, provided detailed background in two scientific poster presentations on its advanced, proprietary coating achievements at the prestigious annual international meeting...
MIV Therapeutics to Highlight Latest HAp Advancements at Leading International Scientific Conference on Biomaterials; MIVT Accepted to Present Proprietary Biocompatible Stent Coating Technology at Society of Biomaterials Meeting
- 2006-01-31
VANCOUVER, British Columbia -- MIV Therapeutics, Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of new generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, announced today that it has been accepted to present some of its latest technology achievements at the annual international meeting...
MIV Therapeutics Highlights 2005 Scientific and Strategic Milestones in Development of New Generation Biomedical Technologies; Year-End Report Cites Achievements in Breakthrough Drug Delivery and Other Solutions for Multi-Billion-Dollar Markets
- 2006-01-04
VANCOUVER, British Columbia -- MIV Therapeutics, Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems, has reported significant progress in a report outlining the achievement of numerous key strategic, corporate and technological objectives for 2005. "The past year has been a time of...
MIV Therapeutics Invited to Present Latest Data on Breakthrough Biofriendly Coating at Leading Medical Device Conference; Invitation Recognizes Potential of MIVT Proprietary Coating to Improve Stent and Drug-Delivery Effectiveness and Safety
- 2005-11-02
VANCOUVER, British Columbia -- MIV Therapeutics, Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of new generation biocompatible coatings and advanced drug delivery systems, and its strategic research partner, the University of British Columbia, have been invited to present their latest achievements in research and development of novel coatings designed to significantly...
MIV Therapeutics' Passive Stent Coatings Accepted for Presentation at Prestigious World Conference on Cardiovascular Therapy; Interim Results of Animal Trials of Proprietary HAp Coating to be Detailed at TCT 2005 Conference
- 2005-09-12
VANCOUVER, British Columbia -- MIV Therapeutics, Inc. (OTCBB:MIVT), a developer of next-generation biocompatible stent coatings and drug delivery technologies for the treatment of cardiovascular disease, announced that interim results of a long-term animal study of its proprietary ultra-thin Hydroxyapatite coating will be featured at this year's 17th annual Transcatheter Cardiovascular...
Conference inspires hope. (Health).(Indian Residential School Survivors Society)(Brief Article)
- 2002-09-01
The conference sponsored by the Indian Residential School Survivors Society titled Survival and Beyond: Hope, Help & Healing Gathering, brought survivors and their families, along with church and government representatives together on the beautiful University of British Columbia campus last month. From July...
- 1
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
- Google Offers Free Downloads of a Million Books 11 votes
- InsideView Disrupts Legacy Business Info Publishers Like Hoover's 9 votes
- Mobile is the New Mass Medium, For Better or Worse 8 votes
- As Income Mobility Falls, American Dream Fades 7 votes
- Newspapers Lose Out As MSNBC.com Snaps Up EveryBlock 6 votes
Presented by American Express